| Endpoint | Cohort A | Cohort B | p value |
| Median OS | 35 months | NR | p = 0.254 |
| Alive at 24 months | 59.6% | 73.4% |
|
| Alive at 36 months | 42.6% | 63.4% |
|
| Median PFS | 15 months | 21 months | p = 0.773 |
| no disease progression at 24 months | 38.4% | 63.0% |
|
| no disease progression at 36 months | 19.2% | 46.9% |
|